#Prostate_Cancer

Thiard News@F4F

@newsen.bsky.social

5 days ago

Clarity Pharmaceuticals Reaches Milestone in Phase III AMPLIFY Trial for Prostate Cancer Imaging Clarity Pharmaceuticals has successfully achieved its target participant enrollment for the Phase III AMPLIFY trial, aiming to enhance prostate cancer imaging and diagnostics.

Clarity Pharmaceuticals Reaches Milestone in Phase III AMPLIFY Trial for Prostate Cancer Imaging #Australia #Sydney #Prostate_Cancer #Clarity_Pharmaceuticals #AMPLIFY_trial

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Blue Earth Diagnostics Presents Promising Study Results for Prostate Cancer Imaging with POSLUMA Recent head-to-head research by Blue Earth Diagnostics highlights the effectiveness of POSLUMA in detecting prostate cancer recurrence, outperforming Piflufolastat.

Blue Earth Diagnostics Presents Promising Study Results for Prostate Cancer Imaging with POSLUMA #USA #Boston #Prostate_Cancer #Blue_Earth_Diagnostics #POSLUMA

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Johnson & Johnson's New Study on Pasritamig Shows Promise Against Advanced Prostate Cancer Recent findings from Johnson & Johnson highlight pasritamig's effectiveness when used with docetaxel for advanced prostate cancer, paving the way for Phase 3 trials.

Johnson & Johnson's New Study on Pasritamig Shows Promise Against Advanced Prostate Cancer #United_States #Johnson_&_Johnson #Prostate_Cancer #Raritan,_NJ #pasritamig

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

K36 Therapeutics Presents Innovative KTX-2001 Study for Prostate Cancer at ASCO Symposium 2026 K36 Therapeutics highlights the KTX-2001 clinical trial for prostate cancer at ASCO 2026, featuring novel treatment strategies in metastatic castration-resistant cases.

K36 Therapeutics Presents Innovative KTX-2001 Study for Prostate Cancer at ASCO Symposium 2026 #USA #San_Francisco #K36_Therapeutics #Prostate_Cancer #KTX-2001

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Microplastics Found in Prostate Tumors: A New Health Concern for Men A recent study reveals alarming levels of microplastics in prostate tumors, prompting questions about their potential link to cancer development.

Microplastics Found in Prostate Tumors: A New Health Concern for Men #United_States #New_York #Health_Risks #Prostate_Cancer #Microplastics

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

SECuRE Trial Advances with Latest Cancer Patient Achieving Undetectable PSA Levels The SECuRE trial reports another success as a participant achieves undetectable PSA levels and negative PSMA PET, showcasing potential in treating mCRPC.

SECuRE Trial Advances with Latest Cancer Patient Achieving Undetectable PSA Levels #Australia #Sydney #Prostate_Cancer #Clarity_Pharmaceuticals #SECuRE_Trial

Amit Singh

@amitsingh121.bsky.social

2 weeks ago

Advanced Prostate Cancer Surgery in Varanasi by Dr Swapnil Patel Prostate cancer is one of the most common cancers affecting men, particularly those above the age of 50. With early diagnosis and the right treatment, it is highly manageable. If you are looking fo…

Looking for #prostate_cancer surgery in #Varanasi? Dr. Swapnil Patel, a renowned cancer surgeon in Varanasi, offers advanced and safe surgical treatment at Upkar Super-Speciality Hospital & Cancer Institute. Know more tinyurl.com/5xpz6cm6

#ProstateCancerSurgeryinVaranasi #DrSwapnilPatel

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

ZERO Prostate Cancer Unveils 2026 Advocacy Summit to Benefit Veterans and Their Care ZERO Prostate Cancer announces the 2026 Advocacy Summit and Veterans Action Convening to enhance care for veterans and raise awareness about prostate cancer.

ZERO Prostate Cancer Unveils 2026 Advocacy Summit to Benefit Veterans and Their Care #United_States #Washington,_D.C. #Prostate_Cancer #ZERO_Prostate_Cancer #Veterans_Action

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Blue Earth Diagnostics to Showcase Key Research on POSLUMA® at ASCO 2026 Blue Earth Diagnostics will present the latest findings on PESLUMA® (flotufolastat F 18) in prostate cancer at ASCO 2026, highlighting its innovative imaging capabilities.

Blue Earth Diagnostics to Showcase Key Research on POSLUMA® at ASCO 2026 #United_States #San_Francisco #Prostate_Cancer #Blue_Earth_Diagnostics #POSLUMA

Thiard News@F4F

@newsen.bsky.social

1 month ago

National Cancer Prevention Month Promotes Screenings and Proton Therapy for Prostate Health In February, National Cancer Prevention Month emphasizes the significance of PSA screenings and precision proton therapy for prostate cancer awareness and treatment.

National Cancer Prevention Month Promotes Screenings and Proton Therapy for Prostate Health #USA #Somerset #Prostate_Cancer #ProCure_Proton_Therapy #PSA_Screening

Thiard News@F4F

@newsen.bsky.social

1 month ago

New Insights from JNCCN Study on Managing Recurring Prostate Cancer Treatments A recent study published in JNCCN reveals the potential benefits of PSMA PET/CT scans in formulating effective treatment plans for recurring prostate cancer patients, changing the treatment landscape significantly.

New Insights from JNCCN Study on Managing Recurring Prostate Cancer Treatments #United_States #Los_Angeles #Prostate_Cancer #NCCN_Guidelines #PSMA_PET

Thiard News@F4F

@newsen.bsky.social

1 month ago

K36 Therapeutics Advances KTX-2001 Phase 1 Trial for Prostate Cancer with New CMO Appointment K36 Therapeutics has completed the first cohort dosing in their Phase 1 clinical trial for KTX-2001, aimed at treating prostate cancer, and introduces a new Chief Medical Officer.

K36 Therapeutics Advances KTX-2001 Phase 1 Trial for Prostate Cancer with New CMO Appointment #USA #Cambridge #K36_Therapeutics #Prostate_Cancer #KTX-2001

Thiard News@F4F

@newsen.bsky.social

1 month ago

Tolmar Introduces Care Partner Corner: A New Resource for Prostate Cancer Caregivers Tolmar, Inc. has launched Care Partner Corner, a digital platform aimed at supporting caregivers of prostate cancer patients with essential resources.

Tolmar Introduces Care Partner Corner: A New Resource for Prostate Cancer Caregivers #US #Buffalo_Grove #Prostate_Cancer #Tolmar #Care_Partner

Thiard News@F4F

@newsen.bsky.social

1 month ago

Francis Medical's Vanquish Water Vapor System Takes a Significant Step in Prostate Treatment Francis Medical has successfully completed the first commercial procedure with the Vanquish Water Vapor System, a promising new treatment for prostate cancer.

Francis Medical's Vanquish Water Vapor System Takes a Significant Step in Prostate Treatment #United_States #Austin #Prostate_Cancer #Francis_Medical #Vanquish_System

Thiard News@F4F

@newsen.bsky.social

1 month ago

New Study Shows ERLEADA® Significantly Lowers Death Risk for Prostate Cancer Patients A recent study indicates that ERLEADA® (apalutamide) significantly lowers the death risk in prostate cancer patients compared to darolutamide over 24 months.

New Study Shows ERLEADA® Significantly Lowers Death Risk for Prostate Cancer Patients #United_States #Horsham #Prostate_Cancer #ERLEADA #apalutamide

Thiard News@F4F

@newsen.bsky.social

1 month ago

ZERO Prostate Cancer Announces Major Veterans Action Event for 2026 ZERO Prostate Cancer is hosting the 2026 Veterans' Action Convening to enhance prostate cancer care for veterans with key stakeholders uniting in Arlington, VA.

ZERO Prostate Cancer Announces Major Veterans Action Event for 2026 #USA #Arlington #Prostate_Cancer #ZERO_Prostate_Cancer #Veterans_Action

Thiard News@F4F

@newsen.bsky.social

2 months ago

ARTBIO Advances with Dosing of AB001 in Phase 1 Trial for Prostate Cancer ARTBIO starts dosing in the ARTISAN trial for AB001, targeting metastatic castration-resistant prostate cancer. This phase 1 study showcases a promising new treatment.

ARTBIO Advances with Dosing of AB001 in Phase 1 Trial for Prostate Cancer #United_States #Cambridge,_Massachusetts #Prostate_Cancer #ARTBIO #AB001

Thiard News@F4F

@newsen.bsky.social

2 months ago

Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements Hagens Berman warns Telix Pharmaceuticals investors of an impending class action due to alleged misrepresentations regarding prostate cancer treatments and supply chains.

Investors in Telix Pharmaceuticals Face Class Action Lawsuit Over Misleading Drug Development Statements #USA #San_Francisco #Prostate_Cancer #Telix_Pharmaceuticals #TLX

Elizabeth

@empower11.bsky.social

2 months ago

115-prostate cancer, confetti isn't paper in Italy and more Confetti isn't paper in Italy, Prostate cancer prevention, Sid and Nancy Vicious, contagious viruses to watch for, strongest muscle in the body and it's not what you think, unusual Majors, quote for 2026 and more mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm mailto:Empower Your Journey A Prostate Cancer Guidebook by Elizabeth Jordan and Daniel Jordan. available on Amazon, eBay , Barnes and Noble more. Website..www.empoweringmendaily.wordpress.com Tiktok @sashastorm59 YouTube @lizjordan2649 Facebook @Why so Serious with Elizabeth and Daniel Podcast  Instagram @Angel Heart Lemon8 @ sashastorm

📣 New Podcast! "115-prostate cancer, confetti isn't paper in Italy and more" on @Spreaker #prostate_cancer

Thiard News@F4F

@newsen.bsky.social

2 months ago

Long-Term Outcomes of Brachytherapy for Prostate Cancer at Okayama University Hospital Okayama University Hospital reports impressive long-term results of brachytherapy for prostate cancer, ensuring patient safety and quality of life.

Long-Term Outcomes of Brachytherapy for Prostate Cancer at Okayama University Hospital #Japan #Prostate_Cancer #Okayama #Okayama_University #Brachytherapy

Thiard News@F4F

@newsen.bsky.social

2 months ago

Clarity Pharmaceuticals to Present Co-PSMA Research at EAU Congress 2026 The Co-PSMA trial by Clarity Pharmaceuticals will be presented at EAU 2026, showcasing its advanced imaging techniques for prostate cancer detection.

Clarity Pharmaceuticals to Present Co-PSMA Research at EAU Congress 2026 #Australia #Sydney #Prostate_Cancer #Clarity_Pharmaceuticals #Co-PSMA

Thiard News@F4F

@newsen.bsky.social

2 months ago

Flagship Pioneering Partners with Pfizer to Target Prostate Cancer with T Cell Medicines Flagship Pioneering and Repertoire Immune Medicines have partnered with Pfizer to develop innovative T cell-targeted therapies for advanced prostate cancer.

Flagship Pioneering Partners with Pfizer to Target Prostate Cancer with T Cell Medicines #USA #Cambridge #Prostate_Cancer #Pfizer #Flagship_Pioneering

Thiard News@F4F

@newsen.bsky.social

3 months ago

FDA Grants Approval for AKEEGA® Innovation in Treating BRCA2-Mutated Prostate Cancer Johnson & Johnson's AKEEGA® is now the first precision therapy approved for BRCA2-mutated metastatic castration-sensitive prostate cancer, showcasing significant treatment advantages.

FDA Grants Approval for AKEEGA® Innovation in Treating BRCA2-Mutated Prostate Cancer #USA #Horsham #Prostate_Cancer #BRCA2 #AKEEGA®

Thiard News@F4F

@newsen.bsky.social

3 months ago

Francis Medical Achieves FDA Clearance for Innovative Prostate Cancer Treatment with Vanquish® System Francis Medical secures FDA 510(k) clearance for its Vanquish® System, a groundbreaking solution for ablation of prostate tissue in intermediate-risk cancer patients.

Francis Medical Achieves FDA Clearance for Innovative Prostate Cancer Treatment with Vanquish® System #USA #Minneapolis #Prostate_Cancer #Francis_Medical #Vanquish

Thiard News@F4F

@newsen.bsky.social

3 months ago

Legal Troubles for Telix Pharmaceuticals over Prostate Cancer Drug Claims and Supply Chain Issues Telix Pharmaceuticals faces a class action lawsuit over alleged misstatements regarding its prostate cancer drug progress and supply chain reliability, raising investor concerns.

Legal Troubles for Telix Pharmaceuticals over Prostate Cancer Drug Claims and Supply Chain Issues #USA #San_Francisco #Securities_Class_Action #Prostate_Cancer #Telix_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

3 months ago

Telix Pharmaceuticals Faces Securities Class Action Over False Statements on Cancer Drug Development and Supply Chain Issues Telix Pharmaceuticals is under legal scrutiny due to allegations of misleading investors regarding its prostate cancer drugs and supply chain stability.

Telix Pharmaceuticals Faces Securities Class Action Over False Statements on Cancer Drug Development and Supply Chain Issues #United_States #San_Francisco #Prostate_Cancer #Telix_Pharmaceuticals #TLX

Thiard News@F4F

@newsen.bsky.social

3 months ago

Nucs AI Revolutionizes Prostate Cancer Treatment with TrackPSMA Launch Nucs AI introduces TrackPSMA, an innovative tool that uses AI for evaluating treatment responses in prostate cancer, benefiting physicians and patients.

Nucs AI Revolutionizes Prostate Cancer Treatment with TrackPSMA Launch #United_States #New_York #Prostate_Cancer #Nucs_AI #TrackPSMA

Thiard News@F4F

@newsen.bsky.social

3 months ago

Prostate Cancer Drugs Market Expected to Reach $28.10 Billion by 2033, Driven by Innovative Therapies The prostate cancer drugs market is projected to grow from $13.22 billion in 2024 to $28.10 billion by 2033, driven by advancements in therapies and increased demand.

Prostate Cancer Drugs Market Expected to Reach $28.10 Billion by 2033, Driven by Innovative Therapies #United_States #Austin #Prostate_Cancer #Drug_Market #DataM_Intelligence

Thiard News@F4F

@newsen.bsky.social

3 months ago

MyOme Introduces Groundbreaking Test for Prostate Cancer Risk Assessment MyOme has launched an integrated polygenic risk score test, enhancing the early detection of prostate cancer through genomic modeling and individualized risk assessments.

MyOme Introduces Groundbreaking Test for Prostate Cancer Risk Assessment #USA #Menlo_Park #Prostate_Cancer #MyOme #genomic_risk

Thiard News@F4F

@newsen.bsky.social

3 months ago

Orthocell's Remplir™ Technology: A Game Changer in Prostate Cancer Surgery Orthocell Limited's Remplir™ is gaining traction in prostate cancer surgeries, enhancing patient recovery and showing promise for future expansion in the market.

Orthocell's Remplir™ Technology: A Game Changer in Prostate Cancer Surgery #Australia #Prostate_Cancer #Perth #Orthocell #Remplir_Technology